Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hippocampal Response to Acute CBD in Psychosis
NCT04778644Phase 2Active, not recruiting
- Sponsor
- Hartford Hospital
- Start
- Dec 2021
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Zygel in schizophrenia, schizoaffective disorder, bipolar I disorder, sponsored by Hartford Hospital. Started Dec 2021; status: active, not recruiting.
02
Drugs
Zygel
03
Conditions
schizophreniaschizoaffective disorderbipolar I disorder
Beyond the preview
Go deeper on NCT04778644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04778644.